Literature DB >> 12121713

Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer.

Koji Doi1, Tetsuya Horiuchi, Masaru Uchinami, Takanori Tabo, Narisato Kimura, Jun Yokomachi, Makoto Yoshida, Kuniyoshi Tanaka.   

Abstract

BACKGROUND: The effects of hepatic ischemia/reperfusion (I/R) on liver metastasis have not been fully examined. We examined hepatic I/R and liver metastasis of colorectal cancer in a rat model; we also quantitated expression of E-selectin (ELAM-1) mRNA after I/R.
MATERIALS AND METHODS: Rats underwent 30 or 60 min of 70% partial hepatic ischemia. After 60 min of reperfusion, rat colon adenocarcinoma cells (RCN-H4) were inoculated intrasplenically. The number of tumor nodules on the liver surface was determined 3 weeks later. Expression of E-selectin mRNA was determined at 1, 3, and 6 h after ischemia by quantitative RT-PCR.
RESULTS: Hepatic I/R promoted liver metastasis of RCN-H4 and induced the expression of E-selectin mRNA in both clamped and unclamped liver lobes. The number of tumor nodules and the expression of E-selectin mRNA after 60 min of ischemia was greater than that after 30 min.
CONCLUSIONS: Hepatic I/R, especially with a long duration of ischemia, induces expression of E-selectin and promotes liver metastasis of colon cancer in rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121713     DOI: 10.1006/jsre.2002.6356

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  23 in total

1.  The impact of portal pedicle clamping on survival from colorectal liver metastases in the contemporary era of liver resection: a matched cohort study.

Authors:  Melanie E Tsang; Paul J Karanicolas; Rogeh Habashi; Eva Cheng; Sherif S Hanna; Natalie G Coburn; Calvin H L Law; Julie Hallet
Journal:  HPB (Oxford)       Date:  2015-09       Impact factor: 3.647

2.  Impact of Intermittent Pringle Maneuver on Long-Term Survival After Hepatectomy for Hepatocellular Carcinoma: Result from Two Combined Randomized Controlled Trials.

Authors:  Kit Fai Lee; Charing C N Chong; Sunny Y S Cheung; John Wong; Andrew K Y Fung; Hon Ting Lok; Paul B S Lai
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

3.  Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.

Authors:  Arno Kornberg; Ulrike Witt; Jennifer Kornberg; Helmut Friess; Katharina Thrum
Journal:  Dig Dis Sci       Date:  2015-01-29       Impact factor: 3.199

4.  Does hepatic ischemia-reperfusion injury induced by hepatic pedicle clamping affect survival after partial hepatectomy for hepatocellular carcinoma?

Authors:  Feng Xia; Wan-Yee Lau; Yanmin Xu; Lin Wu; Cheng Qian; Ping Bie
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

5.  Adverse impact of intermittent portal clamping on long-term postoperative outcomes in hepatocellular carcinoma.

Authors:  S Hao; S Chen; X Yang; C Wan
Journal:  Ann R Coll Surg Engl       Date:  2016-06-06       Impact factor: 1.891

Review 6.  Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation.

Authors:  Dongwei Gao; Sha Li
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

7.  Polysaccharide-K (PSK) may suppress surgical stress-induced metastasis in rat colon cancer.

Authors:  Koji Tamagawa; Tetsuya Horiuchi; Tsutomu Wada; Kenji Bannai; Takao Ando
Journal:  Langenbecks Arch Surg       Date:  2011-12-30       Impact factor: 3.445

Review 8.  Cold-inducible RNA binding protein in cancer and inflammation.

Authors:  Daniel A Lujan; Joey L Ochoa; Rebecca S Hartley
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-01-11       Impact factor: 9.957

9.  Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer.

Authors:  Sébastien Lenglet; François Mach; Fabrizio Montecucco
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

10.  Impact of intermittent portal clamping on the early recurrence of hepatocellular carcinoma after surgery.

Authors:  Shenghua Hao; Shaofei Chen; Xiangwu Yang; Chidan Wan
Journal:  Surg Today       Date:  2016-03-02       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.